Felix Lourdes
Transaction: 06/29/2026
BUY
Change
+100,000
Price
$0.28
Filing
07/13/2026
Type
BUY
Avalon GloboCare Corp.
ALBT • Biotechnology
$0.22
▼ -0.01 (-4.25%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.96M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 105.6%Manageable debt level · 0Weak liquidity · 0.11Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 11, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 1:14 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.22
Change-4.25%
Shares Out8.96M
Market Cap$1.96M
Enterprise Value$2.44M
52W Range0.21 - 2.90
Beta-0.03
P/E-0.10
P/S-5.60
P/B0.17
P/FCF-0.31
EV/Sales-6.97
Price$0.22
Change-4.25%
Shares Out8.96M
Market Cap$1.96M
Enterprise Value$2.44M
52W Range0.21 - 2.90
Beta-0.03
P/E-0.10
P/S-5.60
P/B0.17
P/FCF-0.31
EV/Sales-6.97
EV/EBITDA-0.15
EV/FCF-0.38
Earnings Yield-996.89%
FCF Yield-326.66%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio0.11
Quick Ratio0.11
Volume268.37K
Avg Volume1.51M
Investment DNA
How strong this company looks for long-term investors
51
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Positive revenue growth · 105.6%Manageable debt level · 0Weak liquidity · 0.11Weak profitability
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Ingargiola Luisa
Transaction: 06/29/2026
BUY
Change
+400,000
Price
$0.28
Filing
07/13/2026
Type
BUY
Li Meng
Transaction: 06/29/2026
BUY
Change
+400,000
Price
$0.28
Filing
07/13/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Felix Lourdes | BUY | +100,000 | $0.28 | 06/29/2026 | 07/13/2026 |
| Ingargiola Luisa | BUY | +400,000 | $0.28 | 06/29/2026 | 07/13/2026 |
| Li Meng | BUY | +400,000 | $0.28 | 06/29/2026 | 07/13/2026 |
| Mathews Michael | BUY | +100,000 | $0.28 | 06/29/2026 | 07/13/2026 |
| Sanders Steven Andrew | BUY | +200,000 | $0.28 | 06/29/2026 | 07/13/2026 |
| Lu Wenzhao | BUY | +200,000 | $0.28 | 06/29/2026 | 07/13/2026 |
| Mathews Michael | OTHER | 0 | Not reported | 12/12/2025 | 02/24/2026 |
| Mathews Michael | BUY | — | $1.50 | 12/12/2025 | 02/24/2026 |
| Sanders Steven Andrew | BUY | +8,000 | $5.20 | 01/01/2023 | 03/09/2023 |
| Tauzin W J | BUY | +4,000 | $5.20 | 01/01/2023 | 03/09/2023 |
| Tauzin W J | BUY | +8,000 | $4.30 | 11/01/2022 | 03/09/2023 |
| Tauzin W J | BUY | +8,000 | $5.30 | 05/01/2022 | 03/09/2023 |
| Sanders Steven Andrew | BUY | +8,000 | $8.20 | 01/01/2022 | 03/09/2023 |
| Tauzin W J | BUY | +4,000 | $8.20 | 01/01/2022 | 03/09/2023 |
| Tauzin W J | BUY | +8,000 | $10.30 | 11/01/2021 | 03/09/2023 |
| Tauzin W J | BUY | +8,000 | $10.20 | 05/01/2021 | 03/09/2023 |
| Sanders Steven Andrew | BUY | +8,000 | $11.20 | 01/01/2021 | 03/09/2023 |
| Tauzin W J | BUY | +4,000 | $11.20 | 01/01/2021 | 03/09/2023 |
| Troy Tevi | BUY | +8,000 | $5.20 | 01/01/2023 | 03/08/2023 |
| Stilley William B. III | BUY | +8,000 | $5.20 | 01/01/2023 | 03/08/2023 |